Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
06/2014
06/11/2014CN102973937B Composition with skin beauty effect and oral administration cosmetic containing composition
06/11/2014CN102921002B Japanese encephalitis vaccine cryoprotectant
06/11/2014CN102786582B Tem8 peptides and vaccines comprising the same
06/11/2014CN102727888B Application of anti-human T lymphocyte CD3 surface antigen monoclonal antibody in preparation of drug for treating diabetic nephropathy
06/11/2014CN102600466B Anti-influenza A virus and novel universal epitope vaccine and preparing method thereof
06/11/2014CN102482357B Humanized anti-cdcp1 antibodies
06/11/2014CN102373181B Swine influenza virus-porcine reproductive and respiratory syndrome virus mixed virus-like particle, and preparation method and use thereof
06/11/2014CN102370976B Mixed virus-like particles of swine influenza virus and foot and mouth disease virus, preparation method and application thereof
06/11/2014CN102264897B Rab6kifl/kif20a epitope peptide and vaccines containing the same
06/11/2014CN102183655B New molecular marker CUEDC2 (CUE Domain Containing 2) protein for prognosis judgement in endocrine therapy of breast cancer
06/11/2014CN101687922B Methods of treating ophthalmic diseases
06/11/2014CN101484182B Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses
06/11/2014CN101400793B Novel cancer-associated antigen
06/11/2014CN101148474B Human resource vessel endothelium growth factor monoclonal antibody and preparation method thereof
06/10/2014US8748587 Molecules and methods for modulating TMEM16A activities
06/10/2014US8748585 Antibodies that bind to OX40 and their uses
06/10/2014US8748581 Anti-IL-6R polypeptides and pharmaceutical compositions thereof
06/10/2014US8748580 Device for enhancing immunostimulatory capabilities of T-cells
06/10/2014US8748567 Method for delivery across the blood brain barrier
06/10/2014US8748566 Pharmacologically active antiviral peptides and methods of use
06/10/2014US8748565 Pharmacologically active antiviral peptides and methods of their use
06/10/2014US8748475 Methods and compositions for treating lupus
06/10/2014US8748410 Methods of treating aneurysm
06/10/2014US8748404 DNA vaccination for treatment of multiple sclerosis and insulin-dependent diabetes mellitus
06/10/2014US8748390 Immunogenic epitopes of NGEP antigen
06/10/2014US8748384 Modulation of activity of proneurotrophins
06/10/2014US8748377 Pharmaceutical compositions
06/10/2014US8748373 Hepatitis B virus compositions and methods of use
06/10/2014US8748356 Methods for use in human-adapting monoclonal antibodies
06/10/2014US8748173 Monoclonal antibodies specific for anthrax spores and peptides derived from the antibodies thereof
06/10/2014US8748130 Human papillomavirus / Ii-Key hybrids and methods of use
06/10/2014US8748127 Truncated L1 protein of human papillomavirus type 6
06/10/2014US8748088 Methods of monitoring treatment effectiveness in HIV-infected patients receiveing intensified HAART regimens by measuring episomal 2-LTR circles
06/10/2014US8747886 Nanoimprinting of silk fibroin structures for biomedical and biophotonic applications
06/10/2014US8747870 Polymeric compositions and methods of making and using thereof
06/10/2014US8747869 Lipid vesicle compositions and methods of use
06/10/2014US8747866 Identification of virulence associated regions RD1 and RD5 leading to improve vaccine of M. bovis BCG and M. microti
06/10/2014US8747865 Use of botulinum neurotoxin to alleviate various disorders
06/10/2014US8747864 Staphylococcus aureus proteins and nucleic acids
06/10/2014US8747863 Vaccine for shigella
06/10/2014US8747862 Pathogenic west african human immunodeficiency virus type 2 (HIV-2) group F isolate
06/10/2014US8747861 Multimeric multiepitope influenza vaccines
06/10/2014US8747860 Methods and compositions to modulate antiviral and immune activity responses
06/10/2014US8747859 Porcine reproductive and respiratory syndrome vaccine based on isolate JA-142
06/10/2014US8747857 Calicheamicin derivative-carrier conjugates
06/10/2014US8747856 Antigen binding fragments of an antibody for use in treating or diagnosing ocular diseases
06/10/2014US8747855 Anti human immunodeficiency antibodies and uses thereof
06/10/2014US8747854 Methods of treating moderate to severe hidradenitis suppurativa with anti-TNF-alpha antibodies
06/10/2014US8747852 Methods of treating pterygium
06/10/2014US8747851 Anti-CD33 antibodies and methods for treatment of acute myeloid leukemia using the same
06/10/2014US8747850 Anti-cMET antibody
06/10/2014US8747849 Antibody and uses thereof
06/10/2014US8747847 Monoclonal antibodies for tumor treatment
06/10/2014US8747846 Compositions and methods for immunization against drug resistant Acinetobacter baumannii
06/10/2014US8747845 Methods of treatment by administering antibodies that bind colony stimulating factor 1 receptor (CSF1R)
06/10/2014US8747844 Methods of treating pain
06/10/2014US8747843 Method of treatment and bioassay involving macrophage migration inhibitory factor (MIF) as cardiac-derived myocardial depressant factor
06/10/2014US8747841 Polypeptides and use thereof for treatment of traumatic or degenerative neuronal injury
06/10/2014CA2745618C Anti-ferroportin 1 monoclonal antibodies and uses thereof
06/10/2014CA2711863C Antibody directed against pcrv
06/10/2014CA2668883C Procedure for expressing a tbpb protein on the bacterial surface of an attenuated oral live vaccine as prototype of a meningitis b vaccine
06/10/2014CA2629393C Solid solution perforator containing drug particle and/or drug-adsorbed particles
06/10/2014CA2625506C Immuno-stimulant combination for prophylaxis and treatment of hepatitis c
06/10/2014CA2482634C Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signal transduction
06/10/2014CA2481318C Identification of virulence associated regions rd1 and rd5 leading to improve vaccine of m. bovis bcg and m. microti
06/10/2014CA2459816C Hybrid and tandem expression of neisserial proteins
06/10/2014CA2457322C Process for the maturation of dentritic cells and a vaccine
06/10/2014CA2456864C Adjuvant composition for mucosal and injection delivered vaccines
06/10/2014CA2441287C Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
06/10/2014CA2326598C Fusion proteins of mycobacterium tuberculosis antigens and their uses
06/05/2014WO2014085749A2 Antibodies against clostridium difficile
06/05/2014WO2014085698A1 Compositions and methods for the treatment of cancers associated with a deficiency in the mre11/rad50/nbs1 dna damage repair complex
06/05/2014WO2014085676A1 Ron compositions and methods of use thereof
06/05/2014WO2014085666A1 Methods of characterizing and treating molecular subset of muscle-invasive bladder cancer
06/05/2014WO2014085616A1 Computationally optimized broadly reactive antigens for h1n1 influenza
06/05/2014WO2014085596A1 MONOCLONAL ANTIBODIES AGAISNT ACTIVATED PROTEIN C (aPC)
06/05/2014WO2014085580A1 Methods and compositions involving a flu vaccine
06/05/2014WO2014085527A1 Humanized monoclonal antibodies against activated protein c and uses thereof
06/05/2014WO2014085154A1 Methods for treating renal disease
06/05/2014WO2014084964A1 Vaccine for intrauterine disease
06/05/2014WO2014084859A1 Molecules and methods for modulating tmem16a activities
06/05/2014WO2014084607A1 Ch3 domain variant pair inducing formation of heterodimer of heavy chain constant region of antibody at high efficiency, method for preparing same, and use thereof
06/05/2014WO2014084430A1 Combination anti-cancer therapy
06/05/2014WO2014084333A1 Protozoan protein pertaining to plasmodium infection in liver stage
06/05/2014WO2014084110A1 Sugar chain-attached linker, compound containing sugar chain-attached linker and physiologically active substance or salt thereof, and method for producing same
06/05/2014WO2014083567A2 Methods of preventing tumor metastasis, treating and prognosing cancer and identifying agents which are putative metastasis inhibitors
06/05/2014WO2014083499A1 Method for obtaining antigen-specific human antibodies by in vitro immunisation
06/05/2014WO2014083379A1 Use of anti-fcyri and/or anti-fcyriia antibodies for treating arthritis, inflammation, thrombocytopenia and allergic shock
06/05/2014WO2014083232A1 Use of peptides or antibodies against n-procalcitonin for the treatment of pulmonary lesions
06/05/2014WO2014083194A1 Methods for inducing antibodies
06/05/2014WO2014083173A1 Tumor specific t-cell receptors
06/05/2014WO2014083091A1 Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida
06/05/2014WO2014083060A2 Pseudomonas antigens and antigen combinations
06/05/2014WO2014083040A2 Progranulin as marker for autoimmune disorders
06/05/2014WO2014083019A2 Agent, product and use
06/05/2014WO2014082729A1 Individualized vaccines for cancer
06/05/2014WO2014082163A1 Tox inhibition for the treatment of cancer
06/05/2014WO2014059442A3 Antibody based reagents that specifically recognize toxic oligomeric forms of tau
06/05/2014WO2014058924A3 Antibodies recognizing alpha-synuclein
06/05/2014WO2014055897A3 Human monoclonal anti-pd-l1 antibodies and methods of use
1 ... 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 ... 1823